iCAD develops, engineers, manufactures and markets industry-leading Computer-Aided Detection (CAD) solutions that enable healthcare professionals to identify cancer and other life-threatening conditions earlier by making medical services more effective, more accessible and more affordable for patients worldwide. As the only independent, integrated CAD software and digitizer hardware company, we are able to reduce costs at each stage of the design, production and assembly process. We believe such vertical expertise results in better integration, lower production costs and reduced administrative overhead – factors which allow us to continuously enhance our Mammography, Computed Tomography and Digitizer solutions to pass savings onto our customers. iCAD’s position in the market has earned industry recognition with the receipt of Frost & Sullivan’s Growth Strategy Leadership award and MD Buyline’s continued recognition as “The Winning Combination” of Price and Performance.
Table 1. Compared to 2-D mammography, which yields four images per patient, digital breast tomosynthesis (DBT), or 3-D mammography, produces hundreds of images per patient. While this provides more information for clinicians, the exponential increase in data can result in reader fatigue and burnout, which may ultimately affect patient care.